Cinclus Pharma Holding AB (publ) (STO:CINPHA)
Sweden · Delayed Price · Currency is SEK 16.40
+0.10 (0.61%)
At close: Oct 31, 2025
Cinclus Pharma Holding AB Revenue
Cinclus Pharma Holding AB had revenue of 34.10M SEK in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to 38.68M. In the year 2024, Cinclus Pharma Holding AB had annual revenue of 4.58M, down -23.14%.
Revenue (ttm)
38.68M
Revenue Growth
-23.14%
P/S Ratio
19.73
Revenue / Employee
1.93M
Employees
18
Market Cap
763.22M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.58M | -1.38M | -23.14% |
| Dec 31, 2023 | 5.96M | -4.61M | -43.63% |
| Dec 31, 2022 | 10.57M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 35.85B |
| Swedish Orphan Biovitrum AB | 27.85B |
| Medicover AB | 25.22B |
| Elekta AB | 17.84B |
| Asker Healthcare Group AB | 15.88B |
| AddLife AB | 10.53B |
| Nolato AB | 9.57B |
| Vitrolife AB | 3.51B |